Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26680622 | 0.93 | HSD17B1 (0.59) | HPGDALDH1A1SMN1; SMN2PDK2HSP90AA1 | |
| SCHEMBL1004649 | 0.89 | ALDH1A1 (0.73) | HPGDALDH1A1SMN1; SMN2PDK2HSP90AA1 | |
| SCHEMBL10626283 | 0.82 | ALDH1A1 (0.64) | HPGDALDH1A1SMN1; SMN2PDK2LMNA | |
| SCHEMBL469413 | 0.80 | ALDH1A1 (0.61) | HPGDALDH1A1SMN1; SMN2LMNAPKM | |
| SCHEMBL1300109 | 0.80 | ALDH1A1 (0.61) | HPGDALDH1A1SMN1; SMN2PDK2HSP90AA1 | |
| SCHEMBL949041 | 0.80 | HPGD (0.61) | HPGDALDH1A1SMN1; SMN2PDK2HSP90AA1 | |
| SCHEMBL458926 | 0.80 | ALDH1A1 (0.61) | HPGDALDH1A1SMN1; SMN2CA1CA2 | |
| SCHEMBL6802143 | 0.79 | HSP90AA1 (0.60) | HPGDALDH1A1PDK2HSP90AA1ESR1 | |
| SCHEMBL24783913 | 0.78 | ALDH1A1 (0.67) | HPGDALDH1A1SMN1; SMN2PDK2HSP90AA1 | |
| SCHEMBL1004065 | 0.78 | ALDH1A1 (0.59) | HPGDALDH1A1SMN1; SMN2PDK2HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707859-A | Para-substituted heptamethine quinone cyanine dye and synthetic method and application thereof | 大连理工大学 | 2025-03-28 | — | — | CN | claimed |
| CN-116537266-A | Anti-floating anchor rod waterproof structure and construction method | 华通建设发展集团有限公司 | 2023-08-04 | — | — | CN | claimed |
| US-10240003-B2 | Poly(aryl ether sulfone) composition and method of making | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-03-26 | — | — | US | claimed |
| EP-2773684-B1 | POLY(ARYL ETHER SULFONE) COMPOSITION AND METHOD OF MAKING | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2016-03-30 | — | — | EP | claimed |
| US-9040651-B2 | Poly(aryl ether sulfone) composition, and method of making | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-05-26 | — | — | US | claimed |
| US-20140350207-A1 | POLY(ARYL ETHER SULFONE) COMPOSITION AND METHOD OF MAKING | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2014-11-27 | — | — | US | claimed |
| EP-2773684-A1 | POLY(ARYL ETHER SULFONE) COMPOSITION AND METHOD OF MAKING | SABIC Innovative Plastics IP B.V. (NL) | 2014-09-10 | — | — | EP | claimed |
| WO-2013066784-A1 | POLY(ARYL ETHER SULFONE) COMPOSITION AND METHOD OF MAKING | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2013-05-10 | — | — | WO | claimed |
| US-20130109831-A1 | POLY(ARYL ETHER SULFONE) COMPOSITION, AND METHOD OF MAKING | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2013-05-02 | — | — | US | claimed |
| CN-101553493-A | Novel tricyclic spiropiperidine compounds, their synthesis and their use as modulators of chemokine receptor activity | ASTRAZENECA AB (SE) | 2009-10-07 | — | — | CN | claimed |
| US-20260109724-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4107164-B1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES INC (US) | 2025-12-03 | — | — | EP | disclosed |
| WO-2025202488-A1 | ENHANCER OF NUCLEIC ACID AMPLIFICATION | ROCHE DIAGNOSTICS GMBH (DE) | 2025-10-02 | — | — | WO | disclosed |
| US-20250296938-A1 | Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease | SHY Therapeutics LLC (US) | 2025-09-25 | — | — | US | disclosed |
| US-12391705-B2 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease | SHY THERAPEUTICS, LLC (US) | 2025-08-19 | — | — | US | disclosed |
| US-4146541-A | YELLOW SHADE ON POLYESTERS | CIBA-GEIGY AG (CH) | 1979-03-27 | — | — | US | disclosed |
| US-4140836-A | PRIMERS, WATERPROOFING, ADHESION | PPG INDUSTRIES, INC. (US) | 1979-02-20 | — | — | US | disclosed |
| US-4098740-A | PRIMER COATINGS, POLYEPOXIDES, PHENOLS | PPG INDUSTRIES, INC. (US) | 1978-07-04 | — | — | US | disclosed |
| US-4031051-A | Hydrolyzed reaction product of a polyepoxide with a phenolic compound having a group hydrolyzable to a carboxyl and curing agent therefor | PPG INDUSTRIES, INC. (US) | 1977-06-21 | — | — | US | disclosed |
| US-3960795-A | Hydrolyzed reaction product of a polyepoxide with a phenolic compound having a group hydrolyzable to carboxyl | PPG INDUSTRIES, INC. (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109724-A1 | ANTIVIRAL COMPOUNDS | IRF3, IFNAR1, HAVCR2 | HPGD 3520/4885ALDH1A1 744/4885SMN1; SMN2 111/4885 |
| US-12391705-B2 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease | HRAS, KRAS, NRAS | HPGD 2093/4885ALDH1A1 3359/4885SMN1; SMN2 3538/4885 |
| US-20250296938-A1 | Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Disease | HRAS, KRAS, NRAS | HPGD 2093/4885ALDH1A1 3359/4885SMN1; SMN2 3538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.